About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Mochida Pharmaceutical Co.,Ltd.(4534) Summary

4534
TSE Prime
Mochida Pharmaceutical Co.,Ltd.
2,963
JPY
+10
(+0.34%)
Apr 16, 3:30 pm JST
20.81
USD
Apr 16, 2:30 am EDT
Result
PTS
outside of trading hours
2,961.1
Apr 16, 3:09 pm JST
Summary Chart Historical News Financial Result
PER
18.7
PBR
0.81
Yield
2.70%
Margin Trading Ratio
2.86
Stock Price
Apr 16, 2025
Opening Apr 16, 9:00 am
2,951 JPY 20.61 USD
Previous Close Apr 15
2,953 JPY 20.65 USD
High Apr 16, 9:12 am
2,984 JPY 20.95 USD
Low Apr 16, 12:30 pm
2,936 JPY 20.57 USD
Volume
16,700
Trading Value
0.05B JPY 0.35M USD
VWAP
2959.55 JPY 20.79 USD
Minimum Trading Value
296,300 JPY 2,081 USD
Market Cap
0.11T JPY 0.76B USD
Number of Trades
78
Liquidity & Number of Trades
As of Apr 16, 2025
Liquidity
Mid
1-Year Average
111
1-Year High Aug 2, 2024
456
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 11, 2025 1,000 14,100 14.10
Apr 4, 2025 200 20,900 104.50
Mar 28, 2025 1,200 17,200 14.33
Mar 21, 2025 1,800 16,800 9.33
Mar 14, 2025 1,700 17,200 10.12
Company Profile
Mochida Pharmaceutical Co., Ltd. is a mid-tier pharmaceutical company. Its main product is a medication for hyperlipidemia. The company has strengths in antihypertensive drugs and obstetrics and gynecology products. It also operates in the healthcare sector.
Sector
Pharmaceuticals
While the pharmaceutical-related business is the company's core operation, accounting for the majority of its sales, Mochida Pharmaceutical also engages in the healthcare business. In the pharmaceutical-related business, the company outsources manufacturing to its subsidiary, Mochida Pharmaceutical Plant Co., Ltd., and handles the procurement and sales of these products. Some pharmaceuticals are sold through Mochida Pharmaceutical Sales Co., Ltd. In the healthcare business, the subsidiary Mochida Healthcare Co., Ltd. is responsible for product procurement and sales. Manufacturing for healthcare products is also outsourced to Mochida Pharmaceutical Plant Co., Ltd., similar to pharmaceuticals. The group also includes subsidiaries that handle real estate brokerage, management of buildings and structures, and provide proxy services for accounting and purchasing operations, which Mochida Pharmaceutical also utilizes.